Motivation: Microarrays are widely used to quantify DNA methylation because they are economical, require only small quantities of input DNA and focus on well-characterized regions of the genome. However, pre-processing of methylation microarray data is challenging because of confounding factors that include background fluorescence, dye bias and the impact of germline polymorphisms. Therefore, we present valuable insights and a framework for those seeking the most optimal pre-processing method through a data-driven approach.
Introduction
DNA methylation is one of the most widely studied epigenetic phenomena: it can regulate mRNA abundance and is involved in processes including X-chromosome inactivation and imprinting (Robertson, 2005) . Aberrant DNA methylation is widespread in cancer (Kulis and Esteller, 2010) and linked to disease initiation and progression (Gopalakrishnan et al., 2008; Portela and Esteller, 2010) . A number of techniques have been developed for interrogating the cancer methylome including Illumina Infinium HumanMethylation450 BeadChip array (HM450).
This array includes 482 421 CpG sites, which cover 99% of the reference sequence (RefSeq) genes and 96% of CpG islands (Bibikova et al., 2011; Sandoval et al., 2011) . There are two types of chemical assays on the HM450 array, termed Infinium I and Infinium II. The former has two probes per CpG locus used to separately measure methylated and unmethylated signals. The latter assay has a single probe per CpG locus and uses dual-colour readout to differentiate methylated (green) and unmethylated (red) signals. As with all microarrays, there is a diverse range of technical noise and bias in HM450 experiments, including background fluorescence, colour biases in the red and green channels and different chemical assays (Bock, 2012; Dedeurwaerder et al., 2011) . Infinium I and Infinium II probes also have different methylation distributions, with Infinium II probes having reduced dynamic range (Bibikova et al., 2011; Teschendorff et al., 2013) .
Due to broad usage of the HM450 array, several groups have developed algorithms to pre-process the resulting data to remove technical artefacts. Surprisingly, however, there is no universally applied standard methodology for doing this. Batch effects remain a recurring issue in HM450 array analysis (Sun et al., 2011) . While several comparative studies have used technical replicates as a goldstandard metric to assess the performance of different preprocessing methods (Liu et al., 2016; Marabita et al., 2013; Morris and Beck, 2015; Wang et al., 2015; Wu et al., 2014) , no consensus has emerged. Rather, it appears that the optimal choice of preprocessing method may be a function of the biological context of the samples and experiment. Prostate cancer is the most common nonskin malignancy in men (Haas et al., 2008) , and recent studies have demonstrated that aberrant methylation is strongly associated with prostate cancer relapse (Fraser et al., 2017; White-Al Habeeb et al., 2014) . We therefore sought to identify a HM450 pre-processing technique that can minimize technical variabilities and detect true methylation changes for prostate cancer tissue specimens. We undertook a systematic study of 809 patient samples and evaluated a broad panel of methods based on their ability to: (i) reduce batch effects, (ii) minimize technical variability, (iii) maximize intra-sample correlation and (iv) detect methylation events associated with disease aggressivity (i.e. assay sensitivity) that validate across patient cohorts. We found data-driven separate normalization (Dasen) to be the best pre-processing method for prostate cancer tissues. Overall, this study provides a framework for researchers to select the optimal pre-processing method through a dataset-driven approach and identifies the appropriate preprocessing methodology for methylome studies in prostate cancer tissues.
Materials and methods

Methylation microarray data generation
Illumina Infinium HumanMethylation450 BeadChip kits were used to assess global methylation, using 500 ng of input genomic DNA at the McGill University and Genome Quebec Innovation Centre (Montreal, QC). In total, there were 202 unique samples, of which 114 samples had no replicates, 71 samples were repeated twice, 14 samples repeated three times and 3 samples repeated four times, resulting in 310 samples. These unique samples and their replicates were then randomly hybridized to six different batches and 28 array slides (Supplementary Table S1 ). All samples were obtained from International Cancer Genome Consortium (ICGC) and processed from prostate cancer tissue taken from patients with localized disease. The following ethics approval was obtained for this study from University Health Network Research Ethics Board (REB)-approved study protocols (UHN 06-0822-CE, UHN 11-0024-CE, CHUQ 2012-913:H12-03-192) .
TCGA PRAD dataset
We obtained a total of 499 unique prostate adenocarcinoma (PRAD) level 1 raw IDAT data files along with their clinical information from The Cancer Genome Atlas (TCGA) data portal. Only samples processed using fresh-frozen prostate cancer tissue were selected.
Methylation microarray pre-processing
All methylation pre-processing methods were performed in the R statistical environment (v3.1.3). Quality control was conducted using the minfi package (v1.12.0) (Aryee et al., 2014) and no outliers were detected. Raw data are accessible through the GEO accession number GSE84493. In total, 11 pre-processing methods were applied to both ICGC and TCGA cohort in this study. Of the 11 methods, 9 methods were developed to tackle different technical noises introduced by the array. In this study, we also included two combinational methods (Noob þ BMIQ, Noob þ Funnorm) as their functions had previously been tested in other studies (Fortin et al., 2014; Liu et al., 2016) . Method descriptions were tabulated in Table 1 . All of the above functions are in pre-processing packages minfi (v1.12.0) (Aryee et al., 2014) , wateRmelon (v1.6.0) (Pidsley et al., 2013) , Methylumi (v2.12.0), asmn (v1.2.0) and ChAMP (v1.4.1) (Morris et al., 2014) and are available from BioConductor (v3.1).
Performance-metric calculation
All performance metrics were calculated separately for b-and M-values. We measured batch effects based on the dates of the experiments (batch) and the identities of the array slides on to which the samples were loaded (slide). Batch and slide effects were assessed through unsupervised divisive hierarchical clustering method (DIANA) with the distance calculated from centered Pearson's correlation. The Adjusted Rand Index (ARI) (Hubert and Arabie, 1985) was then computed between the predicted clusters and observed clusters. A lower ARI indicates discordance between the predicted and observed cluster, which in turn suggests less batch-and slidespecific effects. In contrast, higher ARIs indicate that samples cluster together based on batch or slide and that the predicted and observed clusters have non-random concordance. All batch calculations were conducted using the mclust package (v5.0.1) (Fraley and Raftery, 2002) in R (v3.1.3). In addition to these effects, replicate variances (Rep Var) and differences (Rep Diff) were also considered. The former is equal to the median (across samples) of the sum of pairwise replicate variances per probe for each sample, whereas the latter corresponds to the median (across samples) of the count of all pairwise probes within a sample that have replicate differences of at least 0.1. Median inter-array correlations were calculated for each sample using Pearson correlation coefficients (Corr). The median of these correlations was taken to represent an overall correlation value for each method. Next, we ranked individual metrics and calculated the rank product (RP). The Spearman correlations were calculated between metrics to assess their association.
Sample subset analysis
We repeated the above metric assessment with different sample sizes (n ¼ 50, n ¼ 100, n ¼ 150). We performed the sub-sampling 10 times for each sample size, producing 30 different datasets. Pre-processing was conducted separately for each sample subset and permutation. Pre-processing method rankings were conducted the same way as illustrated above for each permutation and sample subset.
Differentially methylated loci
All statistical analyses were performed in the R statistical environment (v3.2.1). Probe filtering was conducted post-normalization. We filtered probes based on SNPs (65 probes) and non-CpG methylation probes (3091 probes). Average intensity levels were taken for technical replicates. Next, for each pre-processing method, we used the DMRcate package (v1.4.2) (Peters et al., 2015) to identify significant differentially methylated probes (DMPs; q < 0.05) between Gleason Score 6 (3 þ 3; n ¼ 43) and 7 (3 þ 4 & 4þ 3; n ¼ 135) patients. Annotation data for chromosome location, probe position and gene symbol were generated using the IlluminaHumanMethylation450kanno.ilmn12.hg19 package (v0.2.1). Similarly, this procedure was also applied to the TCGA PRAD dataset between Gleason Score 6 (3 þ 3; n ¼ 49) and 7 (3 þ 4 & 4 þ 3; n ¼ 243) to generate significant DMPs (q < 0.05) for the 11 different pre-processing methods as well as for raw, unprocessed data.
Data visualization
Visualizations were performed in the R statistical environment (v3.2.1) using the lattice (v0.20-33), latticeExtra (v0.6-26), BPG (v5.4.0) and VennDiagram (v1.6.14) packages (Chen and Boutros, 2011) . Schematics were created in Inkscape (v0.48.4) for Ubuntu.
Results
Dataset and quality control
We evaluated the performances of 11 different pre-processing methods using multiple metrics and validated our findings through the identification of significant differentially methylated probes (DMPs) (Fig. 1) . We focused on 310 samples of primary, localized prostate cancer. To identify outliers in the dataset, we performed quality control after each pre-processing method (Supplementary Figs S1 and S2).
Methylation status can be calculated using two different metrics: b-and M-values. b-values are the ratio of methylated intensities to the sum of methylated and unmethylated intensities. M-values give the log 2 ratio of methylated intensities over unmethylated intensities. b-values are more widely used in the literature due to their direct biological interpretation, but recent studies have recommended calculating differential methylation levels based on M-values since the bounded range of the b-values violates the distributional assumptions underlying many common statistical models (Du et al., 2010) . We consider both b-and M-values in this study to evaluate whether different pre-processing methods are optimal for different measures of methylation.
Metrics of accuracy
Five independent metrics were evaluated for each of the preprocessing methods: (i) batch effects, (ii) slide effects, (iii) variance Note: Methods are ordered based on publication years. Pre-processing methods were compared using five different performance metrics: 1) batch effects, 2) slide effects, 3) replicate variances, 4) replicate differences and 5) intra-sample correlations. Pre-processing method assessment was also repeated 10 times with different sample sizes (n ¼ 50, 100, 150) to test whether sample size will affect the selection of the most optimal pre-processing method. The ranking results were then validated through detecting differentially methylated loci in the TCGA and ICGC cohorts between technical replicates, (iv) the absolute difference in methylation levels between replicates and (v) intra-sample correlations. Batch and slide information were obtained from samples (n ¼ 310) that were loaded onto 28 different array slides and processed across six different dates (Supplementary Table S1 ). Unsupervised machine-learning is one of the most commonly used methods to assess batch effects (Leek et al., 2010) . To assess the bias of unsupervised clustering by these technical covariates, we calculated the Adjusted Rand Index (ARI) (method: DIANA, distance metric: centered Pearson's correlation) as suggested by Milligan et al. to be an effective method for detecting cluster agreement (Milligan and Cooper, 1986) . We applied two different methodologies to measure the impact of technical variabilities: variance and difference. These were used together because previous studies demonstrated that b-values showed heteroscedasticity when used for calculating variance of highly methylated or unmethylated CpG sites (Du et al., 2010; Marabita et al., 2013) . Details on how technical replicates are divided across slides and batches are given in Supplementary Table  S1 . In addition to biological variations across samples, technical variations can also lead to distinguishable differences between samples processed on high-throughput technologies and hence should be removed prior to downstream statistical analyses. To identify those cases, we measured the inter-array correlation between samples after pre-processing as a measure of technical variabilities. To measure which pre-processing method most effectively minimizes batch effects, we compared the ARI for each method. As shown in Supplementary FigureS3A and B, Noob in combination with Funnorm resulted in the smallest batch effect between experimental dates, and this was true for both b-and M-values. With regard to slide-specific effects, PBC was the best when considering b-values, while Noob was again optimal for M-values (Supplementary Fig.  S3C and D). Overall, minimal batch effect after pre-processing was observed for all methods other than ASMN, which showed the worst results in both b-and M-values for correcting batch and slide effects. This suggested that performing colour-channel normalization alone is insufficient to eliminate technical differences. Additionally, to assess how much pre-processing methods can reduce variabilities between replicates, we measured the variances and absolute differences of technical replicates. Consistent with the literature (Fortin et al., 2014; Pidsley et al., 2013) , Dasen placed first in terms of minimizing inter-replicate variances in both b-and Mvalues (it reduced the replicate variances by 67% and 76%, respectively) ( Supplementary Fig.S4A and B) and has the smallest and second-smallest numbers of probes with replicate differences greater than 0.1 in b-and M-values ( Supplementary Fig.S4C and D) . All pre-processing methods showed extremely high correlation (Pearson's r > 0.95), with Dasen exhibiting the highest correlation, suggesting it minimizes technical variation between samples (Supplementary Fig. S5A and B).
Inter-metric correlation
To understand how the performance metrics are associated with each other, we calculated the correlation coefficients between different metrics. When evaluating the performance of different preprocessing methods, it is preferable to select metrics that are independent of one another in order to demonstrate the dynamic characteristic and robustness of our optimal pre-processing method. In Figure 2 , most of the metrics showed weak correlations with each other and non-significant p-values, suggesting these metrics are independent of one another. For example, there are small correlation coefficients between ARI of batch and slide effects for both b-(Spearman's q ¼ 0.08, P ¼ 0.796) and M-values (Spearman's q ¼ 0.44, P ¼ 0.156), the non-significant p-values denote that these metric correlations are indistinguishable from zero and hence non-redundant. However, some metrics do share similarities in our dataset. For instance, the correlation coefficients are high between replicate variances and replicate differences in both b-(Spearman's q ¼ 0.87, P ¼ 0.0003) and M-values (Spearman's q ¼ 0.75, P ¼ 0.007). Overall, we computed pairwise correlation coefficients across all performance metrics for both b-and M-values, which showed weak to no association across 8 pairs of metrics for b-values (Spearman's q < 0.54, P > 0.071) and 8 pairs of metrics for M-values (Spearman's q < 0.56, P > 0.059). This suggests that the metrics selected for evaluating the performance of pre-processing methods were non-redundant.
Between-metric comparison
The HM450 array is susceptible to various technical artefacts, especially batch effects. Therefore, it is crucial to account for technical variability before biological changes in DNA methylation can accurately be assessed. In this study, we expect an ideal pre-processing method can reduce batch effects while at the same time also suppress other technical variations and maximize intra-sample correlations. Hence, we compared the ranking of all metrics to the ranking in the ARI of batch effects to see whether the metrics are complementary to one another (the smaller the ranking, the better the results). In Figure 3A , Dasen showed its ability to minimize both batch and slide effects while using b-values. Some methods demonstrated the ability to eliminate batch effects but not slide-specific effects or vice versa. Given that replicate variances showed high correlation with replicate differences (Fig. 2) , we focused on replicate variances in Figure 3B . Dasen reduced variation between technical replicates and also minimized batch effects using both b-or M-values (Fig. 3B ). In comparison, some methods showed great reduction of replicate variances, at the cost of a reduced ability to remove batch effects. Consistent with Figure 3B , Dasen was able to remove batch effects while retaining high intra-sample correlations (Fig. 3C) . Overall, this suggests Dasen to be an effective pre-processing method that can reduce more than one technical variation and maintain high intra-sample correlations.
Ranking of pre-processing methods
To identify the most optimal method, we used performance metrics to rank the different pre-processing methods: we calculated the rank product of each performance metric and highlighted the order of pre-processing methods from most to least effective ( Fig. 4A and B) . Rank product (RP) is a summary statistic that incorporates all performance metrics simultaneously. The colours and sizes of the dots represent different rankings, as shown in Figure 4A and B. Based on the RP, two of the top three methods are consistent between b-and M-values (Dasen, Noob). Interestingly, with b-and M-values, the raw data (using no pre-processing method) outperform ASMN, indicating this pre-processing method can introduce variability into a dataset. Lemire et al. suggested that M-values might be inappropriate to use when it comes to pre-processing-method comparisons (Lemire et al., 2015) . Conversely, Marabita el al. have argued that M-values are better than b-values when it comes to pipeline performance assessment (Marabita et al., 2013) . Therefore, we compared the method distribution for rank product generated based on b-and M-values to see whether using different measurement methods result in a different pre-processing method ranking. Interestingly, the correlation between the RP of b-and M-values demonstrated high consistency with the ranking method between band M-values (Spearman's q ¼ 0.82, P ¼ 0.002, Fig. 4C ). Thus, our data suggest that Dasen is the most suitable method for preprocessing prostate cancer tissue data.
Different sample subsets
To investigate whether and how sample sizes affect the outcome of pre-processing methods, we applied a sub-sampling strategy. For this exercise, we stratified our total samples into subsets of 50, 100, 150 and 202 (complete dataset) and ranked all pre-processing methods using different subsets for both b-and M-values ( Supplementary   Fig.S6 ). The methods were sorted based on the overall ranking scores across different sample sizes. In Supplementary Figure S6 , we found out that, even though changes in sample selection can alter the ranking of pre-processing method, Dasen was still consistently the top performer for both b-and M-values, irrespective of sample size. This demonstrates the robustness of these pre-processing methods.
Biological application
Gleason Score is the most commonly used grading system in prostate cancer, and is a strong prognostic factor for aggressive disease. Therefore, we used Gleason Score as a variable to test the robustness of our approach. According to a recent study by The Cancer Genome Atlas Research Network (Cancer Genome Atlas Research Network, 2015) , tumours with low Gleason Scores such as Gleason 6 tend to have more normal-like methylation patterns compared to high Gleason Score tumours. As a result, we utilized this characteristic in our dataset as a metric for determining the most optimal preprocessing method; methods that could identify the highest number of probes with differential methylation patterns between Gleason groups 6 and 7 would be selected as a more sensitive method. Significant DMPs (q < 0.05) for each method were calculated based on our cohort. Consistent with our previous findings, Dasen showed more DMPs between Gleason scores, suggesting it was more sensitive at picking up methylation differences between the two groups. We also validated our results in the TCGA PRAD cohort. Raw data from TCGA were downloaded and applied to the same set of 11 different pre-processing methods. The number of significant DMPs, as well as the overlap between our cohort and the TCGA cohort, are plotted in Figure 5A . In addition, overlapping probes between the top four methods are visualized in Figure 5B . Overall, we see that Dasen shows a great overlap with other methods, indicating the biological differences detected by other methods are also detected by Dasen (overlapping probes: Dasen vs. BMIQ: 909; Dasen vs. SWAN: 547; Dasen vs. SQN: 1338).
Discussion
The HM450 array is a frequently employed tool for quantifying large-scale DNA methylation levels. However, due to its design, it is necessary to correct for background noise, perform dye-bias adjustment and correct for Infinium I/II-type bias prior to downstream analyses (Dedeurwaerder et al., 2011 (Dedeurwaerder et al., , 2014 Triche et al., 2013) . Pre-processing of HM450 array data is essential for removing unwanted, non-biological variations; however, reports have suggested that different pre-processing methods can have profound effects on downstream analysis (Marabita et al., 2013) . We confirm that substantial differences in detecting DMPs can occur across different pre-processing methods. As such, selecting the optimal preprocessing method for a given dataset is essential. We evaluated a large prostate cancer cohort, including technical replicates, to evaluate the performance of the 11 most commonly used pre-processing methods. We demonstrate the effects of these different preprocessing methods on correcting batch-and slide-specific effects, reducing replicate variation, increasing inter-sample correlation and improving sensitivities for detecting changes between known patient groups. The datasets provided here may prove to be valuable to the algorithm-development and prostate cancer epigenomics communities. Collectively, our results suggest that Dasen is the most optimal pre-processing method in prostate cancer datasets. Dasen conducts normalization on raw intensities, which have proven to be more effective than using b-or M-values (Pidsley et al., 2013) . This unique feature of the Dasen algorithm may explain why it outperforms PBC or BMIQ methods in the overall rank product, which have been recommended by several other studies (Dedeurwaerder et al., 2014; Marabita et al., 2013; Teschendorff et al., 2013) . Dasen is also designed to correct for multiple biases raised by the HM450 array. For example, background intensities were adjusted for Infinium I probes to match the distribution of Infinium II probes, and quantile normalization was conducted separately on Infinium I and Infinium II probes (Pidsley et al., 2013) . Consistent with our finding that Dasen represents the optimal pre-processing method, several issues have previously been reported with the PBC or BMIQ pre-processing methods. Marabita et al. and Wang et al. have shown that quantile normalization on the raw signal intensity in combination with BMIQ sometimes generates better output than BMIQ alone. PBC has been shown to be effective only when there is a well-defined bimodal distribution (Maksimovic et al., 2012; Teschendorff et al., 2013; Touleimat and Tost, 2012) ; this is in line with our suggestion that characteristics of a dataset play a key role in determining the best pre-processing method. Additionally, previous studies have shown that between-array normalization may dampen true biological variations and potentially decrease data quality when strong global methylation differences exist in the dataset (Dedeurwaerder et al., 2014; Liu et al., 2016; Wang et al., 2015) . We argue that the selection of the optimal pre-processing method is strongly dependent on the nature of the dataset. In fact, our results also suggest that changes in sample selection can alter even the most effective preprocessing method. Fortin et al. have also argued that while Dasen is effective in reducing technical variations, it is comparatively poorer at reducing batch-specific effects and suggests Noob þ Funnorm is a better method (Fortin et al., 2014) . This discrepancy may be due to differences in the type of samples and experimental design used between studies: Fortin et al. measured their reproducibility based on DMPs between samples that have substantial global differences in methylation (kidney clear-cell carcinoma vs. normal) whereas our study focus on all localized prostate cancer samples. In conclusion, our study provides a framework for using a data-driven approach to compare the performance of different preprocessing methods based on both b-and M-values using prostate cancer samples. These data further suggest that it is critical to assess the performance of pre-processing methods through multiple comparison metrics that assess different aspects of data quality. This ensures a systematic evaluation of the pre-processing methods. Although this study was based on Illumina 450k arrays, the general workflow could also be applied to other microarray studies that attempt to identify the most optimal pre-processing methods. Through multiple comparison metrics, Dasen was shown to be the optimal pre-processing method for a large prostate cancer cohort. Collectively, our data suggest that, depending on the tissue types and the characteristics of the dataset, some normalization methods might be more effective at removing technical noise than others. It is, therefore, crucial to carefully optimize and select the preprocessing method based on the experiment hypotheses and study plan before performing any downstream analyses.
